Search
for
Sort by
Research 30 of 1000+
- Alopecia Areata and malignancies: uncertainties clarified by a large-scale population-based study
- Sweet Syndrome as the Presenting Symptom of Relapsed Hairy Cell Leukemia
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report
- ZASTOSOWANIE TERAPII CAR-T W ONKOHEMATOLOGII DZIECIĘCEJ
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Alopecia areata and myasthenia gravis presenting as paraneoplastic phenomena of breast cancer
- Non‐myeloablative stem cell transplants
- Scalp cooling to prevent chemotherapy-induced alopecia
- Alopecia areata, thyroiditis and vitiligo vulgaris in a Japanese patient with smoldering type adult T‐cell leukemia/lymphoma
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations
- The PDGF/PDGFR pathway as a drug target
- Hair loss as a consequence of cancer chemotherapy – physical methods of prevention. A review of the literature
- Oral Manifestations of Hematologic and Nutritional Diseases
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Provenge is Talk of GU Malignancies Congress
- Aberrant Activation of the Hedgehog Signaling Pathway in Malignant Hematological Neoplasms
- The impact of patient-dependent risk factors on morbidity and mortality following gastric surgery for malignancies
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Manifestaciones dermatológicas en pacientes oncológicos pediátricos en un hospital de tercer nivel de Honduras
- Retrospective Comparison of Inflammatory Markers in Severe Acne Vulgaris Patients and Normal Population
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Principles of chemotherapy
- Minoxidil ameliorates myelodysplastic syndrome by targeting Wnt4 while sparing normal hematopoiesis
- Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience